{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:40:29Z","timestamp":1790188829572,"version":"4.1.0"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Monoclonal proteins (M-proteins) serve as critical biomarkers for plasma cell dyscrasias, yet their unique physicochemical properties paradoxically compromise the accuracy of routine laboratory diagnostics. Beyond causing well-documented anomalies in electrophoresis, M-protein interference pervasively affects coagulation, clinical chemistry, and immunoassay platforms, creating analytical artifacts that can fundamentally mislead clinical decision-making. The diagnostic landscape is further complicated by the widespread adoption of therapeutic monoclonal antibodies (t-mAbs), which introduce exogenous \u201cdrug spikes\u201d mimicking disease markers and obscuring therapeutic response assessment. This narrative review elucidates the underlying mechanisms of these interferences, ranging from physical precipitation and chemical binding to immunological hook effects, and synthesizes evidence from recent clinical cohorts and technical evaluations. We critically assess the efficacy of mitigation strategies, highlighting the evolution from traditional techniques like polyethylene glycol precipitation to next-generation solutions involving mass spectrometry and artificial intelligence-driven algorithms. By establishing a comprehensive framework for the recognition and resolution of these artifacts, this article aims to equip clinicians and laboratorians with the tools necessary to ensure that laboratory diagnostics remain a pillar of patient safety.<\/jats:p>","DOI":"10.1515\/cclm-2026-0118","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:02:47Z","timestamp":1778504567000},"page":"1734-1744","source":"Crossref","is-referenced-by-count":3,"title":["M-protein interference in laboratory diagnostics: a comprehensive narrative review of mechanisms and management strategies"],"prefix":"10.1515","volume":"64","author":[{"given":"Shanshan","family":"Liang","sequence":"first","affiliation":[{"name":"Department of the Laboratory Medicine , West China Hospital, Sichuan University , Chengdu , China"},{"name":"Sichuan Clinical Research Centre for Laboratory Medicine, and Clinical Laboratory Medicine Research Centre of West China Hospital , Sichuan University , Chengdu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of the Laboratory Medicine , West China Hospital, Sichuan University , Chengdu , China"},{"name":"Sichuan Clinical Research Centre for Laboratory Medicine, and Clinical Laboratory Medicine Research Centre of West China Hospital , Sichuan University , Chengdu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of the Laboratory Medicine , West China Xiamen Hospital of Sichuan University , Xiamen , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of the Laboratory Medicine , West China Hospital, Sichuan University , Chengdu , China"},{"name":"Sichuan Clinical Research Centre for Laboratory Medicine, and Clinical Laboratory Medicine Research Centre of West China Hospital , Sichuan University , Chengdu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyao","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of the Laboratory Medicine , West China Xiamen Hospital of Sichuan University , Xiamen , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanmin","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of the Laboratory Medicine , West China Hospital, Sichuan University , Chengdu , China"},{"name":"Sichuan Clinical Research Centre for Laboratory Medicine, and Clinical Laboratory Medicine Research Centre of West China Hospital , Sichuan University , Chengdu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of the Laboratory Medicine , West China Hospital, Sichuan University , Chengdu , China"},{"name":"Sichuan Clinical Research Centre for Laboratory Medicine, and Clinical Laboratory Medicine Research Centre of West China Hospital , Sichuan University , Chengdu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2026070213034382586_j_cclm-2026-0118_ref_001","doi-asserted-by":"crossref","unstructured":"Cowan, AJ, Allen, C, Barac, A, Basaleem, H, Bensenor, I, Curado, MP, et al.. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol 2018;4:1221\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2128.","DOI":"10.1001\/jamaoncol.2018.2128"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_002","doi-asserted-by":"crossref","unstructured":"Kyle, RA, Larson, DR, Therneau, TM, Dispenzieri, A, Kumar, S, Cerhan, JR, et al.. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med 2018;378:241\u20139. https:\/\/doi.org\/10.1056\/nejmoa1709974.","DOI":"10.1056\/NEJMoa1709974"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_003","doi-asserted-by":"crossref","unstructured":"Bakker, AJ, M\u00fccke, M. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention. Clin Chem Lab Med 2007;45:1240\u20133. https:\/\/doi.org\/10.1515\/cclm.2007.254.","DOI":"10.1515\/CCLM.2007.254"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_004","doi-asserted-by":"crossref","unstructured":"Li, Y, Zhou, L, Wang, K, Luo, X, Zhang, L, Cai, K. An interference in bilirubin detection: pulmonary marginal zone lymphoma presenting monoclonal cryoglobulin. Clin Chim Acta 2025;567:120066. https:\/\/doi.org\/10.1016\/j.cca.2024.120066.","DOI":"10.1016\/j.cca.2024.120066"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_005","doi-asserted-by":"crossref","unstructured":"Njegovan, M, Margeti\u0107, S, Te\u0161ija Kuna, A, \u0110erek, L, \u0106elap, I, Pavi\u010di\u0107, T, et al.. Interference of M-protein on thrombin time test: a case report. Lab Med 2020;51:545\u20139. https:\/\/doi.org\/10.1093\/labmed\/lmz103.","DOI":"10.1093\/labmed\/lmz103"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_006","doi-asserted-by":"crossref","unstructured":"Wu, X, Yin, Y, Teng, J, Zhang, L, Yang, C. IgM\u03ba paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay: a case report. BMC Immunol 2017;18:32. https:\/\/doi.org\/10.1186\/s12865-017-0213-0.","DOI":"10.1186\/s12865-017-0213-0"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_007","doi-asserted-by":"crossref","unstructured":"van der Helm, MP, Wevers, BA, van Beek, C, Schenk, PW, Bikker-Koornneef, A. M protein interference in renal function assays: a quest for true kidney function. J Appl Lab Med 2025;10:1057\u201363. https:\/\/doi.org\/10.1093\/jalm\/jfaf028.","DOI":"10.1093\/jalm\/jfaf028"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_008","doi-asserted-by":"crossref","unstructured":"Tian, X, Zhao, L, Ma, J, Lu, J, Zhu, TY, Liu, Y, et al.. Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia. Lab Med 2023;54:598\u2013602. https:\/\/doi.org\/10.1093\/labmed\/lmad012.","DOI":"10.1093\/labmed\/lmad012"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_009","unstructured":"Shen, M, Wu, J, Guo, W, Zhang, C, Song, B, Beili, W, et al.. Impact of M protein interference on routine biochemical test items of serum samples. Lab Med 2011;26:730\u20135."},{"key":"2026070213034382586_j_cclm-2026-0118_ref_010","doi-asserted-by":"crossref","unstructured":"Huang, HP, Ran, HM, Li, ZS, Xie, J. A case of POEMS syndrome comprising of a complicated diagnostic procedure: case report. Medicine (Baltim) 2024;103:e37200. https:\/\/doi.org\/10.1097\/md.0000000000037200.","DOI":"10.1097\/MD.0000000000037200"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_011","doi-asserted-by":"crossref","unstructured":"Chen, Y, Chen, Y, Zhou, Y, Zho, F, Wang, S, Zheng, S, et al.. Defects and countermeasures in laboratory diagnosis of rare IgE multiple myeloma. Clin Chim Acta 2022;532:37\u201344. https:\/\/doi.org\/10.1016\/j.cca.2022.05.011.","DOI":"10.1016\/j.cca.2022.05.011"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_012","doi-asserted-by":"crossref","unstructured":"Pelletier, S, Florent, L, Gillery, P, Oudart, JB. Interference of therapeutic monoclonal antibodies with electrophoresis and immunofixation of serum proteins: state of knowledge and systematic review. Clin Chem Lab Med 2025;63:2355\u201365. https:\/\/doi.org\/10.1515\/cclm-2025-0678.","DOI":"10.1515\/cclm-2025-0678"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_013","doi-asserted-by":"crossref","unstructured":"Murray, DL, Puig, N, Kristinsson, S, Usmani, SZ, Dispenzieri, A, Bianchi, G, et al.. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an international myeloma working group mass spectrometry committee report. Blood Cancer J 2021;11:24. https:\/\/doi.org\/10.1038\/s41408-021-00408-4.","DOI":"10.1038\/s41408-021-00408-4"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_014","doi-asserted-by":"crossref","unstructured":"Ibeh, N, Baine, I, Rudon, LF, Lomas-Francis, C, Jhang, JS, Galdon, P, et al.. Use of an in-house trypsin-based method to resolve the interference of daratumumab. Transfusion 2021;61:3000\u20137. https:\/\/doi.org\/10.1111\/trf.16635.","DOI":"10.1111\/trf.16635"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_015","doi-asserted-by":"crossref","unstructured":"Kirchhoff, DC, Murata, K, Thoren, KL. Use of a daratumumab-specific immunofixation assay to assess possible immunotherapy interference at a major cancer center: our experience and recommendations. J Appl Lab Med 2021;6:1476\u201383. https:\/\/doi.org\/10.1093\/jalm\/jfab055.","DOI":"10.1093\/jalm\/jfab055"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_016","doi-asserted-by":"crossref","unstructured":"Jimenez, A, Scholl, AR, Wang, B, Schilke, M, Carlsen, ED. Characteristics of isatuximab-derived interference in serum protein electrophoresis and immunofixation, and an absence of sustained in\u00a0vivo interference due to belantamab mafodotin and denosumab. Clin Biochem 2024;127-128:110761. https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110761.","DOI":"10.1016\/j.clinbiochem.2024.110761"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_017","doi-asserted-by":"crossref","unstructured":"Thoren, K, Menad, S, Nouadje, G, Mac\u00e9, S. Isatuximab-specific immunofixation electrophoresis assay to remove interference in serum M-Protein measurement in patients with multiple myeloma. J Appl Lab Med 2024;9:661\u201371. https:\/\/doi.org\/10.1093\/jalm\/jfae028.","DOI":"10.1093\/jalm\/jfae028"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_018","doi-asserted-by":"crossref","unstructured":"Shirouchi, Y, Kaihara, K, Sekita, T, Amano, N, Nakayama, K, Miyake, K, et al.. Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-\u03ba monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents. Cancer Med 2024;13:e70128. https:\/\/doi.org\/10.1002\/cam4.70128.","DOI":"10.1002\/cam4.70128"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_019","doi-asserted-by":"crossref","unstructured":"Baloda, V, McCreary, EK, Goscicki, BK, Shurin, MR, Wheeler, SE. Tixagevimab plus cilgavimab does not affect the interpretation of electrophoretic and free light chain assays. Am J Clin Pathol 2023;159:10\u20133. https:\/\/doi.org\/10.1093\/ajcp\/aqac137.","DOI":"10.1093\/ajcp\/aqac137"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_020","doi-asserted-by":"crossref","unstructured":"Noori, S, Verkleij, CPM, Zajec, M, Langerhorst, P, Bosman, PWC, de Rijke, YB, et al.. Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference. Clin Chem Lab Med 2021;59:1963\u201371. https:\/\/doi.org\/10.1515\/cclm-2021-0399.","DOI":"10.1515\/cclm-2021-0399"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_021","doi-asserted-by":"crossref","unstructured":"McCudden, C, Axel, AE, Slaets, D, Dejoie, T, Clemens, PL, Frans, S, et al.. Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference. Clin Chem Lab Med 2016;54:1095\u2013104. https:\/\/doi.org\/10.1515\/cclm-2015-1031.","DOI":"10.1515\/cclm-2015-1031"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_022","unstructured":"Han, J, Cheng, X, Wu, J, Ji, W, Qian, D, Zhang, J, et al.. Interference of monoclonal immunoglobulin to immunoglobulin determination by immunoturbidimetry and nephelometry. Lab Med 2019;34:197\u2013201."},{"key":"2026070213034382586_j_cclm-2026-0118_ref_023","doi-asserted-by":"crossref","unstructured":"Keren, DF, Bocsi, G, Billman, BL, Etzell, J, Faix, JD, Kumar, S, et al.. Laboratory detection and initial diagnosis of monoclonal gammopathies. Arch Pathol Lab Med 2022;146:575\u201390. https:\/\/doi.org\/10.5858\/arpa.2020-0794-cp.","DOI":"10.5858\/arpa.2020-0794-CP"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_024","doi-asserted-by":"crossref","unstructured":"Zajec, M, Langerhorst, P, VanDuijn, MM, Gloerich, J, Russcher, H, van Gool, AJ, et al.. Mass spectrometry for identification, monitoring, and minimal residual disease detection of M-Proteins. Clin Chem 2020;66:421\u201333. https:\/\/doi.org\/10.1093\/clinchem\/hvz041.","DOI":"10.1093\/clinchem\/hvz041"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_025","doi-asserted-by":"crossref","unstructured":"Muccio, S, Hirtz, C, Descloux, S, Fedeli, O, Mac\u00e9, S, Lehmann, S, et al.. A sensitive high-resolution mass spectrometry method for quantifying intact M-protein light chains in patients with multiple myeloma. Clin Chim Acta 2024;552:117634. https:\/\/doi.org\/10.1016\/j.cca.2023.117634.","DOI":"10.1016\/j.cca.2023.117634"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_026","doi-asserted-by":"crossref","unstructured":"Wijnands, C, Armony, G, Noori, S, Gloerich, J, Bonifay, V, Caillon, H, et al.. An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients. Clin Chem Lab Med 2024;62:2507\u201318. https:\/\/doi.org\/10.1515\/cclm-2024-0306.","DOI":"10.1515\/cclm-2024-0306"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_027","doi-asserted-by":"crossref","unstructured":"Elfert, E, Kaminski, WE, Matek, C, Hoermann, G, Axelsen, EW, Marr, C, et al.. Expert-level detection of M-proteins in serum protein electrophoresis using machine learning. Clin Chem Lab Med 2024;62:2498\u2013506. https:\/\/doi.org\/10.1515\/cclm-2024-0222.","DOI":"10.1515\/cclm-2024-0222"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_028","unstructured":"Zaharudin, MR, S, CT, Samsudin, IN, H, AH. Serum separation abnormality in a multiple myeloma patient. Malays J Pathol 2023;45:123\u20137."},{"key":"2026070213034382586_j_cclm-2026-0118_ref_029","doi-asserted-by":"crossref","unstructured":"Jacobs, JFM, Turner, KA, Graziani, MS, Frinack, JL, Ettore, MW, Tate, JR, et al.. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins. Clin Chem Lab Med 2020;58:547\u201359. https:\/\/doi.org\/10.1515\/cclm-2019-1105.","DOI":"10.1515\/cclm-2019-1105"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_030","doi-asserted-by":"crossref","unstructured":"Reiter, R, Mann, C, Nockher, WA. Beyond the hydrashift assay: the utility of isoelectric focusing for therapeutic antibody and paraprotein detection. Clin Chem Lab Med 2025;63:1766\u201372. https:\/\/doi.org\/10.1515\/cclm-2025-0352.","DOI":"10.1515\/cclm-2025-0352"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_031","doi-asserted-by":"crossref","unstructured":"Teuwen, JTJ, Ritzen, LFL, Knapen-Portz, YM, Ludwiczek, PK, Damoiseaux, J, van Beers, J, et al.. Identifying therapeutic monoclonal antibodies using target protein collision electrophoresis reflex assay to separate the wheat from the chaff. J Immunol Methods 2023;522:113552. https:\/\/doi.org\/10.1016\/j.jim.2023.113552.","DOI":"10.1016\/j.jim.2023.113552"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_032","doi-asserted-by":"crossref","unstructured":"Murray, DL. Bringing mass spectrometry into the care of patients with multiple myeloma. Int J Hematol 2022;115:790\u20138. https:\/\/doi.org\/10.1007\/s12185-022-03364-2.","DOI":"10.1007\/s12185-022-03364-2"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_033","doi-asserted-by":"crossref","unstructured":"Chen, IH, Xiao, H, Daly, T, Li, N. Improved host cell protein analysis in monoclonal antibody products through molecular weight cutoff enrichment. Anal Chem 2020;92:3751\u20137. https:\/\/doi.org\/10.1021\/acs.analchem.9b05081.","DOI":"10.1021\/acs.analchem.9b05081"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_034","doi-asserted-by":"crossref","unstructured":"Baloda, V, Shurin, MR, Wheeler, SE. Pilot verification of a novel approach to remove electrophoretic interference of the therapeutic monoclonal antibody daratumumab. J Appl Lab Med 2022;7:910\u20135. https:\/\/doi.org\/10.1093\/jalm\/jfab174.","DOI":"10.1093\/jalm\/jfab174"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_035","doi-asserted-by":"crossref","unstructured":"Daves, M, Piccin, A, Vicidomini, C, De Luisi, A, Mega, A. Utility of serum indices in a particular case of serum protein electrophoresis. Biochem Med 2022;32:030802. https:\/\/doi.org\/10.11613\/bm.2022.030802.","DOI":"10.11613\/BM.2022.030802"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_036","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, \u00c1, Deza, S, Maroto-Garc\u00eda, J, Varo, N. Capillary blood in core laboratories: current and future challenges. Clin Chem Lab Med 2025;64:752\u201366. https:\/\/doi.org\/10.1515\/cclm-2025-0888.","DOI":"10.1515\/cclm-2025-0888"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_037","doi-asserted-by":"crossref","unstructured":"Sunusi, U, Chen, L, Li, N, Lee, JKY, Siddiqui, I, Goodhue, E, et al.. Prevalence and clinical impact of pseudohypercalcemia in paraproteinemia: a case and cohort study. J Clin Med 2025;14:7676. https:\/\/doi.org\/10.3390\/jcm14217676.","DOI":"10.3390\/jcm14217676"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_038","doi-asserted-by":"crossref","unstructured":"Ma, L, Zhao, Z, Racine-Brzostek, SE, Yang, HS. A rare case of persistent pseudohypobicarbonatemia arising from chemistry analyzer-specific interference. Clin Chim Acta 2021;519:308\u201310. https:\/\/doi.org\/10.1016\/j.cca.2021.05.025.","DOI":"10.1016\/j.cca.2021.05.025"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_039","unstructured":"Xu, D, Meng, T, Chen, J, Li, H. Comparative analysis of four methods for eliminating M protein interference in serum uric acid detection. Chin J Clin Lab Sci 2024;42:728\u201332."},{"key":"2026070213034382586_j_cclm-2026-0118_ref_040","doi-asserted-by":"crossref","unstructured":"Wang, D, Li, P, Su, W, Hou, L, Han, J, Zhang, Y, et al.. From interference to insight: pseudo-lipidemia led to the diagnosis of Waldenstr\u00f6m macroglobulinemia. BMC Cardiovasc Disord 2025;25:170. https:\/\/doi.org\/10.1186\/s12872-025-04588-w.","DOI":"10.1186\/s12872-025-04588-w"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_041","doi-asserted-by":"crossref","unstructured":"Hager, HB, Bolstad, N, Warren, DJ, Ness, MV, Seierstad, B, Lindberg, M. Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies. Clin Chem Lab Med 2021;59:663\u20139. https:\/\/doi.org\/10.1515\/cclm-2020-1411.","DOI":"10.1515\/cclm-2020-1411"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_042","doi-asserted-by":"crossref","unstructured":"Freeman, J, Wilson, K, Spears, R, Shalhoub, V, Sibley, P. Performance evaluation of four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2. Clin Biochem 2015;48:1097\u2013104. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.05.021.","DOI":"10.1016\/j.clinbiochem.2015.05.021"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_043","doi-asserted-by":"crossref","unstructured":"Mineva, EM, Schleicher, RL, Chaudhary-Webb, M, Maw, KL, Botelho, JC, Vesper, HW, et al.. A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2015;407:5615\u201324. https:\/\/doi.org\/10.1007\/s00216-015-8733-z.","DOI":"10.1007\/s00216-015-8733-z"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_044","doi-asserted-by":"crossref","unstructured":"Luzzi, VI, Scott, MG, Gronowski, AM. Negative thyrotropin assay interference associated with an IgGkappa paraprotein. Clin Chem 2003;49:709\u201310. https:\/\/doi.org\/10.1373\/49.4.709.","DOI":"10.1373\/49.4.709"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_045","doi-asserted-by":"crossref","unstructured":"Mesl\u00e9, V, Bories, E, Bost, C, Alzieu, F, Jamme, T. Unexpected discovery of CRP analytical interference: a case report. Clin Biochem 2024;127:110781. https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110781.","DOI":"10.1016\/j.clinbiochem.2024.110781"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_046","doi-asserted-by":"crossref","unstructured":"Sarkar, R. A simple method to overcome paraproteinemic interferences in chemistry and immunoassays. Lab Med 2024;55:802\u20137. https:\/\/doi.org\/10.1093\/labmed\/lmae042.","DOI":"10.1093\/labmed\/lmae042"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_047","doi-asserted-by":"crossref","unstructured":"Fermand, JP, Bridoux, F, Dispenzieri, A, Jaccard, A, Kyle, RA, Leung, N, et al.. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood 2018;132:1478\u201385. https:\/\/doi.org\/10.1182\/blood-2018-04-839480.","DOI":"10.1182\/blood-2018-04-839480"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_048","doi-asserted-by":"crossref","unstructured":"Leung, N, Bridoux, F, Batuman, V, Chaidos, A, Cockwell, P, D\u2019Agati, VD, et al.. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal gammopathy research group. Nat Rev Nephrol 2019;15:45\u20139. https:\/\/doi.org\/10.1038\/s41581-018-0077-4.","DOI":"10.1038\/s41581-018-0077-4"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_049","doi-asserted-by":"crossref","unstructured":"Thai, HT, Gaudel, N, Cerou, M, Ayral, G, Fau, JB, Sebastien, B, et al.. Joint modelling and simulation of M-protein dynamics and progression-free survival for alternative isatuximab dosing with pomalidomide\/dexamethasone. Br J Clin Pharmacol 2022;88:2052\u201364. https:\/\/doi.org\/10.1111\/bcp.15123.","DOI":"10.1111\/bcp.15123"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_050","doi-asserted-by":"crossref","unstructured":"Scholl, AR, Korentzelos, D, Forns, TE, Brenneman, EK, Kelm, M, Datto, M, et al.. Characterization of casirivimab plus imdevimab, sotrovimab, and bamlanivimab plus Etesevimab-derived interference in serum protein electrophoresis and immunofixation electrophoresis. J Appl Lab Med 2022;7:1379\u201387. https:\/\/doi.org\/10.1093\/jalm\/jfac064.","DOI":"10.1093\/jalm\/jfac064"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_051","doi-asserted-by":"crossref","unstructured":"Vakili, H, Koorse Germans, S, Dong, X, Kansagra, A, Patel, H, Muthukumar, A, et al.. Complete depletion of daratumumab interference in serum samples from plasma cell myeloma patients improves the detection of endogenous M-Proteins in a preliminary study. Diagnostics 2020;10:219. https:\/\/doi.org\/10.3390\/diagnostics10040219.","DOI":"10.3390\/diagnostics10040219"},{"key":"2026070213034382586_j_cclm-2026-0118_ref_052","doi-asserted-by":"crossref","unstructured":"Guo, Y, Wei, B, Dai, W, Zhang, G. Falsely elevated estradiol levels due to heterophile antibody interference: a case report and literature review. Endocr Metab Immune Disord Drug Targets 2025. https:\/\/doi.org\/10.2174\/0118715303352682250219044719 [Epub ahead of print].","DOI":"10.2174\/0118715303352682250219044719"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0118\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:21:38Z","timestamp":1783005698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0118\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,7,24]]}},"alternative-id":["10.1515\/cclm-2026-0118"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2026-0118","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]}}}